Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Is GoodRx Stock a Buy?

TheMotleyFool

0 0

After a nice share run-up post-IPO, America's No. 1 drug app company by popularity, GoodRx Holdings (NASDAQ: GDRX), is down over 30% from its high and remains below its debut price of $46 per share. Now, many investors are wondering if they should buy the dip on some shares.

After all, who wouldn't be excited about investing in a company that genuinely helps make prescription drugs affordable for all? As it turns out, there is a key reason why GoodRx is a great business, but may not be a great investment. Can the company hold its ground against a mega-competitor that's about to enter the industry? Let's find out together.

Image source: Getty Images.

Source Fool.com

Like: 0

GDRX

Share